An early study from 1991 stated the correlation between MYB expression and doxorubicin resistance in LoVo/Dx CRC cells, which showed distinctly higher MYB mRNA levels than doxorubicin-sensitive LoVo cells[57]. Here, MYB is linked to colorectal carcinoma.